Best GHK-Cu Providers in 2026 — Ranked & Reviewed
GHK-Cu is a copper-binding peptide prescribed for skin, hair, and tissue repair, available compounded as an injection or a topical. As with every peptide in this category, the meaningful difference between sellers is whether a licensed clinician is involved at all. The providers below all prescribe through one, and each is independently scored.
Lowest verified price: $99/mo (Auren Rx, ongoing rate)33 providers compared
New to GHK-Cu? Read our full GHK-Cu guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
33 ghk-cu providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin - Nationwide Coverage
a low all-in starter price on compounded GLP-1s, with every dose price published up front
From /moCheck pricingCoverage50 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141SermorelinTB-500Tesamorelin Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
From /moCheck pricingCoverage50 statesMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelinflat all-in compounded GLP-1 pricing at every dose, with a choice of named pharmacies
From /moCheck pricingCoverage43 statesMedicationsGHK-CuGlutathioneNAD+SermorelinGLP-1 weight care alongside HRT, from board-certified physicians
From /moCheck pricingCoverageCheck intakeMedicationsGHK-Culow-cost, physician-led compounded GLP-1 with peptide and hormone options
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin- Best Budget
month-to-month compounded GLP-1s at one price for every dose, with the pharmacy named
From /mo$145Coverage50 statesMedicationsNAD+GlutathioneSermorelinGHK-Cu GLP-1 alongside men's and women's hormone-health programs
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
Nationwide Coverage a low all-in starter price on compounded GLP-1s, with every dose price published up front | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141SermorelinTB-500Tesamorelin | 50 states | Visit → | |
 Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | 50 states | Visit → | |
 flat all-in compounded GLP-1 pricing at every dose, with a choice of named pharmacies | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | 43 states | Visit → | |
 GLP-1 weight care alongside HRT, from board-certified physicians | Check pricing | GHK-Cu | Check intake | Visit → | |
 low-cost, physician-led compounded GLP-1 with peptide and hormone options | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin | 50 states | Visit → | |
Best Budget month-to-month compounded GLP-1s at one price for every dose, with the pharmacy named | $145 | NAD+GlutathioneSermorelinGHK-Cu | 50 states | Visit → | |
 GLP-1 alongside men's and women's hormone-health programs | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → |
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to GHK-Cu. The GHK-Cu price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes GHK-Cu but publishes no price for it — you are quoted after the consultation.
ShedRx
Verified partnerBest for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Pepti
Best for: a low all-in starter price on compounded GLP-1s, with every dose price published up front
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s, with a published shipping list of 49 states plus DC. Injectable semaglutide starts at $99 and tirzepatide at $159 per 28-day supply, rising with dose to $199 and $319. Each price covers medication, physician review, labs, refill management and shipping, with no membership fee. Pepti is a platform, not a prescriber, and does not bill insurance.
Score Breakdown
Pros
- ✓Injectable semaglutide starts at $99 and tirzepatide at $159 all-in, with no membership fee on top.
- ✓Publishes the exact price for every dose of both drugs, so you can see what titrating up will cost before you start.
- ✓Publishes a shipping list of 49 states plus DC, and a provider denial means a full refund.
- ✓Names the reviewing physician, Dr. Gene Lee MD, and posts third-party sterility and potency results by lot.
Cons
- ✗Billed every 28 days rather than monthly, so you pay 13 times a year, not 12.
- ✗Price rises with dose: semaglutide tops out at $199 and tirzepatide at $319 per supply.
- ✗The site says it serves 50 states, but its own list leaves out Oklahoma and counts DC instead.
- ✗No compounding pharmacy is named in advance; you only learn it from your medication label.
- ✗The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- ✗Cash-pay only with no insurance billing, and medication can't be refunded once it ships.
YourHealthRx
Best for: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform that connects patients with independent clinicians and 503A compounding pharmacies in all 50 states (not DC). Compounded semaglutide is $170/month and tirzepatide $210/month month-to-month, with lower 3- and 6-month upfront plans and the same price at every dose. Oral tablets are also offered. Compounded meds aren't FDA-approved, the pharmacy isn't named, and refunds are rarely available once intake starts.
Score Breakdown
Pros
- ✓Available in all 50 states through a multi-state licensed clinician network
- ✓Compounded semaglutide and tirzepatide in two formats: weekly injectable or daily oral dissolving tablet
- ✓Flat price that doesn't change as your dose increases
- ✓Prices shown upfront, and the monthly price includes prescription, medication, and delivery
- ✓Lower rates on 3- and 6-month plans, plus a broad peptide catalog and lab testing
Cons
- ✗YourHealthRx is a platform, not the prescriber or pharmacy; prescribing runs through partner clinicians
- ✗Compounded medications are not FDA-approved, and are not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy partner is not named
- ✗Refunds are generally not available once intake or clinician review has started
- ✗The lowest advertised rates need a 6-month upfront payment or a promo code; month-to-month is $170 (semaglutide) or $210 (tirzepatide)
- ✗Not available in DC, some injectables can't ship to California, and some states require a video visit
- ✗No LegitScript certification displayed
PreventiveMD
Best for: flat all-in compounded GLP-1 pricing at every dose, with a choice of named pharmacies
PreventiveMD is a cash-pay telehealth platform for GLP-1 weight loss and peptide therapy. Compounded semaglutide is $119/mo and tirzepatide $139/mo month-to-month, all-in at every dose, dropping to $83 and $97/mo on a 12-month prepaid plan. Brand Wegovy, Zepbound, and Foundayo cost a $49/mo membership plus medication. A US-licensed provider reviews your intake within 24-48 hours, and you can choose among four named 503A pharmacies at checkout.
Score Breakdown
Pros
- ✓Compounded semaglutide $119/mo and tirzepatide $139/mo month-to-month, the same all-in price at every dose
- ✓Prepaying cuts the price to as low as $83/mo (semaglutide) or $97/mo (tirzepatide) on a 12-month plan
- ✓Names its four 503A pharmacies (Empower, Drug Crafters, Boudreaux's, Midwest Compounders) and lets you pick one at checkout
- ✓Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
- ✓Asynchronous provider review within 24-48 hours, no video visit or labs required
- ✓Card is only pre-authorized at checkout and charged once a provider approves
- ✓Supplies and shipping included; HSA/FSA cards accepted with itemized receipts on request
- ✓Available in 43 states and publishes the short list of states it doesn't serve
Cons
- ✗The lowest advertised prices ($83 and $97/mo) require paying for 12 months upfront
- ✗Not available in Alaska, Arkansas, Mississippi, New Jersey, New Mexico, South Dakota, West Virginia, or DC
- ✗Brand Wegovy, Zepbound, and Foundayo add a $49/mo fee on top of medication starting at $149-$299/mo
- ✗Orders become non-refundable once the pharmacy begins filling them
- ✗Plans auto-renew by default until you turn renewal off
- ✗No labs ordered, so it isn't a substitute for ongoing primary care
Kina
Best for: GLP-1 weight care alongside HRT, from board-certified physicians
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $179/month (plus a $50 physician consult; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
Score Breakdown
Pros
- ✓Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- ✓Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- ✓Verifiable LegitScript certification (seal ID 50917967)
- ✓GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- ✓Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Cons
- ✗Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Built for women navigating menopause — less tailored if that is not your situation
- ✗A separate $50 physician consultation fee applies on top of the medication price
- ✗The compounding pharmacy partner is not named, and the full list of served states is not published
How to choose a GHK-Cu provider
GHK-Cu is a copper-binding peptide sold two very different ways: as a cosmetic topical you can buy without a prescription, and as a compounded injectable that requires one. The price gap between them is not a discount — it is a different product.
What to look for
- Topical or injectable. Most of the published human work on GHK-Cu is topical, for skin and hair. Injectable GHK-Cu is compounded and prescription-only, with far less human data. Decide which you are buying before comparing prices.
- Concentration, stated. Topical GHK-Cu products vary enormously in copper-peptide concentration and most do not disclose it. A seller that publishes the percentage is giving you the only number that makes two products comparable.
- Evidence kept in proportion. Skin and wound-repair claims have the most support; systemic anti-aging claims have the least. A clinic that distinguishes the two is more trustworthy than one that does not.
Red flags to avoid
- “Research peptides” sold without a prescriber. Vials labeled “for research use only — not for human consumption” are sold outside the drug-approval system entirely, with no verified identity, purity, or sterility. Every peptide in this category is prescription-only in the US; if no licensed clinician is writing a prescription, you are not buying the same product.
- No named 503A or 503B compounding pharmacy. There is no FDA-approved finished product for these peptides, so every legitimate dose comes from a compounding pharmacy. A clinic that will not name the pharmacy it dispenses through is asking you to trust an unverifiable supply chain.
- “FDA-approved” claimed for a compounded peptide. Compounded drugs are not FDA-approved, and saying otherwise is a marketing violation, not a technicality. Some peptides once held an approval for a different indication in a discontinued brand — that is not the same as the compounded product being approved.
- Outcome claims with no trial behind them. Most peptides in this category have mechanistic or early-phase evidence, not randomized outcome trials. A clinic promising a specific fat-loss, muscle, or anti-aging result is selling ahead of the evidence — check our evidence review for the molecule before you commit.
- No baseline labs or follow-up for hormone-axis peptides. Growth-hormone secretagogues raise IGF-1, which is the point and also the thing to monitor. A clinic that never measures it cannot tell whether you are responding or over-dosed.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.